Comparative bioavailability of two brands of ciprofloxacin: an Indian study
Suthakaran, C.; Rajaram, S.; Adithan, C.
International Journal of Clinical Pharmacology Therapy and Toxicology 30(2): 66-68
1992
ISSN/ISBN: 0174-4879 PMID: 1551749 Document Number: 388254
A randomized crossover study was carried out to determine the bioavailability of two commercially available brands of ciprofloxacin after oral administration in healthy volunteers. There were no significant differences in the pharmacokinetic parameters that characterize bioavailability between the two brands. It is therefore concluded that there is no bioinequivalence between these ciprofloxacin brands.
Document emailed within 1 workday
Related Documents
Seth, S.D.; Beotra, A.; Seth, S. 1995: Comparative bioavailability of two brands of ciprofloxacin Journal of the Association of Physicians of India 43(5): 327-330Trejo, D.; Toledo, A.; Carrasco-Portugal, M.d.C.; Aguilar-Cota, M.ía.E.; Herrera, J.E.; Flores-Murrieta, F.J. 2003: Comparative bioavailability of two oral formulations of ciprofloxacin Proceedings of the Western Pharmacology Society 46: 134-135
Hagos, B.; Nganga, J.N.; Juma, F.D.; Ndegwa, P. 1989: A comparative study of the neutralising capacity of eight brands of antacids East African Medical Journal 66(6): 408-410
Terhaag, B.; Le Petit, G.; Pachaly, C.; Feller, K. 1985: The in vitro liberation and the bioavailability of different brands of griseofulvin in plasma and urine in man International Journal of Clinical Pharmacology Therapy and Toxicology 23(9): 475-479
Smith, T.C.; Kinkel, A.W. 1977: Bioavailability of two brands of quinidine gluconate administered on a multiple-dose regimen Current Therapeutic Research 21(1): 128-134
Osato, M.S. 1999: Effect of two balanced salt solutions on the bioavailability of ofloxacin and ciprofloxacin Advances in Therapy 16(5): 200-209
Farouk, A.; Regdon, G.; Mallalatif, G.; Hadi, I.A. 1984: Comparative study on ampicillin bioavailability from capsule and suppositories Acta Pharmaceutica Hungarica 54(5): 193-199
Le Conte, P.; Simon, N.; Bourrier, P.; Merit, J.B.; Lebrin, P.; Bonnieux, J.; Potel, G.; Baron, D. 2001: Acute pyelonephritis. Randomized multicenter double-blind study comparing ciprofloxacin with combined ciprofloxacin and tobramycin Presse Medicale 30(1): 11-15
Canada, A.T.; Little, A.H. 1975: The bioavailability of enteric-coated acetylsalicylic acid: a comparative study in reheumatoid arthritis, i Current Therapeutic Research 18(5): 727-732
Di Nola, F.; Soranzo, M.L. 1983: Comparative study, on healthy volunteers, of the bioavailability of 2 pharmaceutical formulations of oral cofosfolactamines. Trials between subjects Minerva Medica 74(6): 239-248
Hasan, M.M.; Najib, N.M.; Muti, H. 1993: A comparative bioavailability study on two sustained-release formulations of diclofenac sodium following a single dose administration International Journal of Clinical Pharmacology Therapy and Toxicology 31(8): 387-391
Bhandari, P. 1999: Bioequivalence of two brands of sustained release theophylline brands Journal of the Association of Physicians of India 47(4): 461
Seth, B.L. 1992: Comparative pharmacokinetics and bioavailability study of percutaneous absorption of diclofenac from two topical formulations containing drug as a solution gel or as an emulsion gel Arzneimittel-Forschung 42(2): 120-122
Meena, P.D.; Chattopadhyay, C.; Kumar, A.; Awasthi, R.P.; Singh, R.; Kaur, S.; Thomas, L.; Goyal, P.; Chand, P. 2011: Comparative study on the effect of chemicals on Alternaria blight in Indian mustard--a multi-location study in India Journal of Environmental Biology 32(3): 375-379
Irshaid, Y.M.; Rawashdeh, N.M.; Zghol, F.; Jalal, I.; Najib, N.M. 1995: Comparative pharmacokinetics of 2 brands of cefuroxime following a single intramuscular injection International Journal of Clinical Pharmacology and Therapeutics 33(5): 285-293
Saengsuwan, P.; Jaruratanasirikul, S.; Jullangkoon, M.; Aeinlang, N. 2010: Comparative study of pharmacokinetics/ pharmacodynamics of ciprofloxacin between 400 mg intravenously every 8 h and 400 mg intravenously every 12 h in patients with gram negative bacilli bacteremia Journal of the Medical Association of Thailand 93(7): 784-788
Jutasompakorn, P.; Kongpatanakul, S.; Pongnarin, P.; Sathirakul, K.; Chatsiricharoenkul, S. 2015: Comparative Fasting Bioavailability of 2 Cilostazol Formulations in Healthy Thai Volunteers: An Open-Label, Single-Dose, Randomized, 2-Way Crossover Study Journal of the Medical Association of Thailand 98(9): 910-915
Odelola, H.A.; Jaiyebo, O.; Anukam, P.A.; Akanni, A.O. 1989: Comparative in-vitro antibacterial activity of two brands of antibiotics against clinical isolates of some bacterial genera African Journal of Medicine and Medical Sciences 18(4): 307-310
Spasov, A.A.; Petrov, V.I.; Iezhitsa, I.N.; Kravchenko, M.S.; Kharitonova, M.V.; Ozerov, A.A. 2010: Comparative study of magnesium salts bioavailability in rats fed a magnesium-deficient diet Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 2: 29-37
Benninger, P.; Cooper, A.; Moisan, R.; Patel, P.; Elvin, A.; Thiessen, J.J. 2004: A comparative clarithromycin bioavailability study: determination of clarithromycin and 14-(R)-hydroxyclarithromycin under fasting and fed conditions International Journal of Clinical Pharmacology and Therapeutics 42(6): 342-349